Literature DB >> 2304087

Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis.

R B Hostetter1, L B Augustus, R Mankarious, K F Chi, D Fan, C Toth, P Thomas, J M Jessup.   

Abstract

Although the serum level of carcinoembryonic antigen (CEA) is directly associated with a poor prognosis in human colorectal carcinoma (CRC), its function is obscure. As a member of the immunoglobulin supergene family, CEA may be involved with intercellular recognition and binding and facilitate attachment of CRC to sites of metastasis. In an experimental metastasis model of CRC in athymic nude mice, a systemic injection of CEA enhanced experimental liver metastasis and implantation in liver by a weakly metastatic CRC. This CRC also selectively bound to CEA that was attached to plastic. Thus, CEA may function as an attachment factor for CRC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304087     DOI: 10.1093/jnci/82.5.380

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  45 in total

1.  The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer.

Authors:  C X Zheng; W H Zhan; J Z Zhao; D Zheng; D P Wang; Y L He; Z Q Zheng
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women.

Authors:  Jon J Ladd; Tina Busald; Melissa M Johnson; Qing Zhang; Sharon J Pitteri; Hong Wang; Dean E Brenner; Paul D Lampe; Raju Kucherlapati; Ziding Feng; Ross L Prentice; Samir M Hanash
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-25

3.  Blocking the attachment of cancer cells in vivo with DNA aptamers displaying anti-adhesive properties against the carcinoembryonic antigen.

Authors:  Erik W Orava; Aws Abdul-Wahid; Eric H-B Huang; Amirul Islam Mallick; Jean Gariépy
Journal:  Mol Oncol       Date:  2013-04-11       Impact factor: 6.603

4.  Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells.

Authors:  A Gangopadhyay; D A Lazure; P Thomas
Journal:  Clin Exp Metastasis       Date:  1998-11       Impact factor: 5.150

5.  Hexapeptide fragment of carcinoembryonic antigen which acts as an agonist of heterogeneous ribonucleoprotein M.

Authors:  Nicholas Y Palermo; Peter Thomas; Richard F Murphy; Sándor Lovas
Journal:  J Pept Sci       Date:  2012-03-06       Impact factor: 1.905

6.  Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells.

Authors:  Aws Abdul-Wahid; Marzena Cydzik; Nicholas W Fischer; Aaron Prodeus; John E Shively; Anne Martel; Samira Alminawi; Zeina Ghorab; Neil L Berinstein; Jean Gariépy
Journal:  Int J Cancer       Date:  2018-08-09       Impact factor: 7.396

7.  Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 in colorectal cancer.

Authors:  E Polat; U Duman; M Duman; A E Atici; E Reyhan; T Dalgic; E B Bostanci; S Yol
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

8.  Metastatic potential of human colorectal carcinoma SW1222 cells transfected with cDNA encoding carcinoembryonic antigen.

Authors:  J Hashino; Y Fukuda; S Oikawa; H Nakazato; T Nakanishi
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

9.  Carcinoembryonic antigen-stimulated THP-1 macrophages activate endothelial cells and increase cell-cell adhesion of colorectal cancer cells.

Authors:  Cary B Aarons; Olga Bajenova; Charles Andrews; Stanley Heydrick; Kristen N Bushell; Karen L Reed; Peter Thomas; James M Becker; Arthur F Stucchi
Journal:  Clin Exp Metastasis       Date:  2007-05-09       Impact factor: 5.150

10.  Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response.

Authors:  L C Scott; T R J Evans; J Cassidy; S Harden; J Paul; R Ullah; V O'Brien; R Brown
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.